Andreas Ihrig

7PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPacific Peoples cultural determinants of healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 07, 2025
Urologists' Estimation of Online Support Group Utilization Behavior of Their Patients With Newly Diagnosed Nonmetastatic Prostate Cancer in Germany: Predefined Secondary Analysis of a Randomized Controlled Trial.

Philipp Karschuck, Christer Groeben, Rainer Koch

|Sep 12, 2023
Response to the letter to editor: Neurocognitive deficits attributed to androgen deprivation therapy in patients with prostate cancer should be reconsidered.

Andreas Ihrig, Pascal Marino Pernt, Stefanie Zschäbitz

|Jul 19, 2023
Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer.

Andreas Ihrig, Pascal Marino Pernt, Stefanie Zschäbitz

|Feb 22, 2023
Couples coping with advanced prostate cancer: an explorative study on decision-making preferences, self-efficacy and fear of progression.

Till Johannes Bugaj, Imad Maatouk, Tobias Hanslmeier

|Sep 17, 2020
The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients.

Andreas Ihrig, I Maatouk, H C Friederich

|Aug 20, 2020
Patient expectations are better for immunotherapy than traditional chemotherapy for cancer.

Andreas Ihrig, Jenniffer Richter, Carsten Grüllich

Pageof 2

Frequent Collaborators

5 joint publications

Johannes Huber

4 joint publications

Hans-Christoph Friederich

4 joint publications

Imad Maatouk

3 joint publications

Till Johannes Bugaj